Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA

被引:24
作者
Fell, PL
Hudson, AJ
Reynolds, MA
Usman, N
Akhtar, S
机构
[1] ASTON UNIV,DEPT PHARMACEUT & BIOL SCI,INST PHARMACEUT SCI,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND
[2] RIBOZYME PHARMACEUT INC,BOULDER,CO 80301
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1997年 / 7卷 / 04期
关键词
D O I
10.1089/oli.1.1997.7.319
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Catalytic RNA or ribozymes have important potential applications as molecular biological tools in the study of gene expression and as therapeutic inhibitors of disease-causing genes, Very little is known, however, about the cellular uptake mechanisms of exogenously delivered synthetic ribozymes, In this study, we have characterized the uptake properties of a synthetic, 2'-O-methyl-modified ribozyme containing U4/U7 amino groups within the catalytic core of the hammerhead motif, The cellular uptake of the internally [P-32]-radiolabeled hammerhead ribozyme in U87-MG glioma cells was temperature, energy, and pH dependent and involved an active process that could be competed with cold ribozyme of the same chemistry and sequence, an all 2'-O-methyl-modified ribozyme of the same sequence, antisense PS-ODNs, and a variety of other polyanions (salmon sperm DNA, spermidine, dextran sulfate, and heparin), Subcellular distribution studies of fluorescently labeled ribozymes confirmed an extranuclear, punctate localization similar to that observed for an endosomal marker, dextran, Our study highlights that hammerhead ribozymes, despite exhibiting a defined secondary structure, enter cells by an endocytic mechanism that appears to be similar to that reported for a variety of antisense ODNs. These observations should facilitate the development of more efficient delivery systems.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 52 条
[1]   Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake, and hemolytic activity of oligonucleotides [J].
Agrawal, S ;
Iadarola, PL ;
Temsamani, J ;
Zhao, QY ;
Shaw, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) :2219-2224
[2]   The influence of polarized epithelial (Caco-2) cell differentiation on the cellular binding of phosphodiester and phosphorothioate oligonucleotides [J].
Akhtar, S ;
Beck, GF ;
Hawley, P ;
Irwin, WJ ;
Gibson, I .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (03) :197-206
[3]  
Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2
[4]   Anti-HIV therapy with antisense oligonucleotides and ribozymes: Realistic approaches or expensive myths? [J].
Akhtar, S ;
Rossi, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :159-165
[5]   In vivo studies with antisense oligonucleotides [J].
Akhtar, S ;
Agrawal, S .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (01) :12-18
[6]  
Akhtar S., 1995, DELIVERY STRATEGIES
[7]   Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells [J].
Beck, GF ;
Irwin, WJ ;
Nicklin, PL ;
Akhtar, S .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1028-1037
[8]  
BEIGELMAN L, 1995, J BIOL CHEM, V270, P25701
[9]  
Bennett R M, 1993, Antisense Res Dev, V3, P235
[10]   DNA-BINDING TO HUMAN-LEUKOCYTES - EVIDENCE FOR A RECEPTOR-MEDIATED ASSOCIATION, INTERNALIZATION, AND DEGRADATION OF DNA [J].
BENNETT, RM ;
GABOR, GT ;
MERRITT, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2182-2190